Argentina

AstraZeneca is expected to start producing 400 million COVID-19 vaccines for Latam by early 2021

Production of 400 million doses of a COVID-19 vaccine for Latin America could begin early next year, an executive at the pharmaceutical company AstraZeneca Plc said Thursday, as the number of coronavirus deaths in the region increases to nearly 230,000. In partnership with the governments of Mexico and Argentina

AstraZeneca is expected to start producing 400 million COVID-19 vaccines for Latam by early 2021 Read More »